{"AllianceGenome": "1962", "HGNC": "1962", "MIM": "118507", "_id": "1141", "_version": 1, "accession": {"genomic": ["AF077186.2", "AF174495.5", "AJ001935.1", "AJ001936.1", "AJ001937.1", "AJ001938.1", "AJ001939.1", "AL592078.10", "AX719090.1", "CH471121.2", "CP068277.2", "NC_000001.11", "NC_060925.1", "NG_008027.1"], "protein": ["AAB40115.1", "AAD45422.1", "AAH75040.1", "AAH75041.1", "BAG36255.1", "CAA05108.1", "CAA37320.1", "CAA69692.1", "CAD88996.1", "EAW53192.1", "NP_000739.1", "P17787.1", "XP_016855669.1", "XP_054190044.1"], "rna": ["AK313470.1", "BC075040.2", "BC075041.2", "NM_000748.3", "R40506.1", "U62437.1", "X53179.1", "XM_017000180.3", "XM_054334069.1", "XR_001736952.3", "XR_008485885.1", "Y08415.1"], "translation": [{"protein": "XP_054190044.1", "rna": "XM_054334069.1"}, {"protein": "AAH75040.1", "rna": "BC075040.2"}, {"protein": "BAG36255.1", "rna": "AK313470.1"}, {"protein": "AAB40115.1", "rna": "U62437.1"}, {"protein": "NP_000739.1", "rna": "NM_000748.3"}, {"protein": "CAA37320.1", "rna": "X53179.1"}, {"protein": "AAH75041.1", "rna": "BC075041.2"}, {"protein": "CAA69692.1", "rna": "Y08415.1"}, {"protein": "XP_016855669.1", "rna": "XM_017000180.3"}]}, "alias": ["EFNL3", "nAChRB2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2023-02-07T17:00:00.000Z", "disease_label": "sleep-related hypermotor epilepsy", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0000030", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ed365ac2-8cfa-4ae9-8fef-323dd596a22f-2023-02-07T170000.000Z", "sop": "SOP9"}}, "ensembl": {"gene": "ENSG00000160716", "protein": ["ENSP00000357461", "ENSP00000489703", "ENSP00000490474"], "transcript": ["ENST00000368476", "ENST00000635876", "ENST00000636034", "ENST00000636695", "ENST00000637900"], "translation": [{"protein": "ENSP00000357461", "rna": "ENST00000368476"}, {"protein": "ENSP00000489703", "rna": "ENST00000636034"}, {"protein": "ENSP00000490474", "rna": "ENST00000637900"}], "type_of_gene": "protein_coding"}, "entrezgene": "1141", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.6255870035, "exp_mis": 260.194519024, "exp_syn": 128.099824658, "lof_z": 2.9622167690758, "mis_z": 4.55429778574018, "mu_lof": 9.65938017416e-07, "mu_mis": 2.36909512836e-05, "mu_syn": 1.14424822112e-05, "n_lof": 2.0, "n_mis": 110.0, "n_syn": 96.0, "p_li": 0.720254345017317, "p_null": 0.000628416508618252, "p_rec": 0.279117238474064, "syn_z": 1.75823756945241}, "bp": 1509, "cds_end": 154548408, "cds_start": 154540520, "n_exons": 6, "nonpsych": {"exp_lof": 11.3178338123, "exp_mis": 235.391614248, "exp_syn": 115.833194235, "lof_z": 3.01202689254323, "mis_z": 4.84550366067956, "mu_lof": 9.65938017416e-07, "mu_mis": 2.36909512836e-05, "mu_syn": 1.14424822112e-05, "n_lof": 1.0, "n_mis": 88.0, "n_syn": 85.0, "p_li": 0.903918675577909, "p_null": 0.000202449204939715, "p_rec": 0.0958788752171518, "syn_z": 1.80370530497654}, "nontcga": {"exp_lof": 11.6048632069, "exp_mis": 239.368297974, "exp_syn": 117.841199538, "lof_z": 2.78132931190512, "mis_z": 4.52007391975989, "mu_lof": 9.65938017416e-07, "mu_mis": 2.36909512836e-05, "mu_syn": 1.14424822112e-05, "n_lof": 2.0, "n_mis": 99.0, "n_syn": 91.0, "p_li": 0.646415289114564, "p_null": 0.00129159870970848, "p_rec": 0.352293112175727, "syn_z": 1.56558135010825}, "transcript": "ENST00000368476.3"}, "exons": [{"cdsend": 154575932, "cdsstart": 154568044, "chr": "1", "position": [[154567777, 154568108], [154569461, 154569607], [154569791, 154569836], [154570257, 154570367], [154571188, 154572161], [154575761, 154580010]], "strand": 1, "transcript": "NM_000748", "txend": 154580010, "txstart": 154567777}], "exons_hg19": [{"cdsend": 154548408, "cdsstart": 154540520, "chr": "1", "position": [[154540253, 154540584], [154541937, 154542083], [154542267, 154542312], [154542733, 154542843], [154543664, 154544637], [154548237, 154552486]], "strand": 1, "transcript": "NM_000748", "txend": 154552486, "txstart": 154540253}], "generif": [{"pubmed": 11054772, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11771745, "text": "Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease."}, {"pubmed": 11906688, "text": "CHRNB2 is a logical candidate for influencing smoking behavior and nicotine dependence"}, {"pubmed": 11906688, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11952766, "text": "autosomal dominant nocturnal frontal lobe epilepsy probands were analyzed for the presence of V287L and V287M mutations in the CHRNB2 gene. No mutations in the analyzed region of CHRNB2 found."}, {"pubmed": 12185808, "text": "Mutations of the gene encoding CHRNB2 may be linked to nocturnal frontal lobe epilepsy."}, {"pubmed": 12214130, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12663058, "text": "CHRNB2 subunit is expressed in the soma of the majority of pyramidal cells, with the most beta 2 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma."}, {"pubmed": 12681012, "text": "Mutations in genes coding for the alpha 4 and beta 2 subunits of the neuronal nicotinic acetylcholine receptor receptor (CHRN) are known to cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)."}, {"pubmed": 15026168, "text": "A significant association for Alzheimer's disease is observed for a non-coding polymorphism in CHRNB2 subunit."}, {"pubmed": 15033200, "text": "Nicotinic acetylcholine receptor beta 2 subunit polymorphisms are not a useful marker for prediction of the susceptibility.to febrile seizures."}, {"pubmed": 15033200, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15046869, "text": "Reduced gene expression of the alpha4beta2 nicotinic receptor in the cerebral cortex is a major feature of the neurochemical pathology of autism, whilst post-transcriptional abnormalities of both this and the alpha7 subtype are apparent in the cerebellum"}, {"pubmed": 15154117, "text": "A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men"}, {"pubmed": 15681842, "text": "alpha3beta2 nicotinic receptor has a role in regulating gene expression after tobacco exposure in oral epithelial cells"}, {"pubmed": 15964197, "text": "Here, we report a new CHRNB2 mutation located in transmembrane region 3 (M3), outside the known ADNFLE mutation cluster. The CHRNB2 mutation I312M, which occurred de novo in twins, markedly increases the receptor's sensitivity to acetylcholine."}, {"pubmed": 16023355, "text": "nicotinic modulation of thalamo-cortical circuitry as a key component in the control of conscious awareness in dementia with Lewy bodies"}, {"pubmed": 16174636, "text": "M1 domains on both alpha4 and beta2 play an important role for efficient expression of extracellular domain alpha4beta2 nAChRs that are high fidelity structural models of full-length alpha4beta2 nAChR"}, {"pubmed": 16183856, "text": "nicotine-induced up-regulation of alpha4beta2 acetylcholine receptors resulted primarily from an increase in assembly from large pools of unassembled subunits, but up-regulation also resulted from a 5-fold increase in the lifetime in the surface membrane"}, {"pubmed": 16314871, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16407231, "text": "analysis of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors"}, {"pubmed": 16636791, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16636791, "text": "Our present study provided the first line of direct evidence suggesting that the CHRNA4 gene combined with CHRNB2 receptor gene may be linked to schizophrenia."}, {"pubmed": 16928859, "text": "Greater beta2*-nAChR availability during early abstinence may impact the ability of smokers to maintain abstinence."}, {"pubmed": 17192785, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17226798, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17226798, "text": "This study provides the first evidence for association between the CHRNB2 gene and nicotine- and alcohol-related phenotypes, and suggests that polymorphisms in CHRNB2 may be important in mediating early responses to nicotine and alcohol."}, {"pubmed": 17373692, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17385675, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17559419, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17900292, "text": "To our knowledge, this is the third family reported presenting a mutation in CHRNB2 in nocturnal frontal lobe epilepsy."}, {"pubmed": 18043764, "text": "results do not demonstrate a significant genetic difference in 7 markers from the CHRNA4 and CHRNB2 genes between schizophrenia patients who smoke and those who do not"}, {"pubmed": 18226955, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18242781, "text": "These results in living human subjects corroborate postmortem reports of decline in high affinity nicotine binding with age and may aid in elucidating the role of beta(2)-nAChRs in cognitive aging."}, {"pubmed": 18534558, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18534914, "text": "Genetic testing revealed the CHRNB2 mutation I312M in transmembrane region 3 (M3) of the neuronal nicotinic acetylcholine receptor."}, {"pubmed": 18593715, "text": "An SNP (rs2072661) in the 3' UTR region of the CHRNB2 has an impact on abstinence rates at the end of treatment and after a 6-month follow-up period."}, {"pubmed": 18593715, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18762859, "text": "CHRNA4 and CHRNB2 do not play a major role in Japanese schizophrenia."}, {"pubmed": 18762859, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18830724, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18991851, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18991851, "text": "Results suggest that neither CHRNA4 nor CHRNB2 plays a major role in Japanese methamphetamine-use disorder."}, {"pubmed": 19058950, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19063970, "text": "Results report that overexpression of VILIP-1 enhances ACh responsiveness, whereas siRNA against VILIP-1 reduces alpha4beta2 nAChR currents of hippocampal neurons."}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19101612, "text": "results indicate activation of protein kinase A & protein kinase C leads to phosphorylation of alpha4beta2 receptors at different stages of receptor formation & maturation & has different effects on expression & function of alpha4beta2 receptors"}, {"pubmed": 19156168, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19259974, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19279256, "text": "Extracellular beta1-beta2 and cysteine-loops bridge the pre-M1 transmembrane domain and M2-M3 linker to transduce agonist binding into channel gating."}, {"pubmed": 19482438, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19482438, "text": "There was no evidence of association of any of the SNPs in CHRNAB2 (rs2072661, rs4845378) or CHRNAB3 (rs4953, rs6474413) with smoking status (p=0.30) or, among daily smokers, of association with cotinine levels (p=0.08)."}, {"pubmed": 19620239, "text": "analysis of the agonist bindnig site of alpha4beta2 nicotinic acetylcholine receptors"}, {"pubmed": 19755656, "text": "association of a 3' untranslated region polymorphism (rs2072661) in the nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene with quitting success in response to nicotine versus placebo patch during a short-term test of patch effects."}, {"pubmed": 19874574, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20231857, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20371741, "text": "Data suggests that beta(2)*-nAChRs play a role in pain sensitivity but not pain tolerance during tobacco smoking withdrawal."}, {"pubmed": 20413850, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20441771, "text": "Using high-resolution NMR spectroscopy, we solved the structure of the entire transmembrane domain (TM1234) of the beta2 subunit. We found that TM1234 formed a four-helix bundle in the absence of the extracellular and intracellular domains."}, {"pubmed": 20534741, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20574532, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20603624, "text": "A novel mutant mouse harboring the human ADNFLE mutation in the Chrnb2 gene was generated and used to study the roles of beta2* nicotinic receptors in complex biological processes including the activity-rest cycle, natural reward and anxiety."}, {"pubmed": 20649589, "text": "Used analysis of non-stationary noise to estimate the maximal probability the nicotinic alpha4beta2 receptor is open."}, {"pubmed": 20677014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20736995, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20854418, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20854418, "text": "variation in the promoter region of CHRNB2 gene may be important in mediating levels of expression of the beta2 nicotinic receptor subunit, which may be associated with variation in subjective response to nicotine"}, {"pubmed": 20880607, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20881005, "text": "The high sensitivity to activation and desensitization of (alpha4beta2)alpha5 nAChRbeta2 by nicotine results in a narrow concentration range in which activation and desensitization curves overlap."}, {"pubmed": 20923852, "text": "Concatameric pentamers and pentamers formed from combinations of trimers, dimers, and monomers of alpha6beta2beta3* acetylcholine receptors exhibit similar properties, indicating that the linkers between subunits do not alter their functional properties."}, {"pubmed": 20943775, "text": "A signaling cascade involving Janus kinase-2 and signal transducer and activator of transcription 3 mediates anti-inflammatory effects through alpha4beta2 nicotinic receptors."}, {"pubmed": 21252231, "text": "Expression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits in the yeast Pichia pastoris: glycosylation is not required for ligand binding."}, {"pubmed": 21287502, "text": "mutations of CHRNB2 and CHRNA2 genes may be rare in Chinese autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)"}, {"pubmed": 21396349, "text": "human alpha4beta2 nicotinic receptors adopt a secondary/tertiary fold similar to that of the Torpedo nicotinic receptor with a large proportion of both alpha-helix and beta-sheet, but exhibit a substantially increased thermal stability."}, {"pubmed": 21451042, "text": "The carboxy-terminal domain of nicotinic alpha4beta2 receptor can be moved from the alpha4 to the beta2 subunit and still result in potentiation."}, {"pubmed": 21536845, "text": "Sympathetic alpha3beta2-nAChRs mediate basilar artery neurogenic nitrergic vasodilation in swine."}, {"pubmed": 21606948, "text": "Evidence for significant association between common sequence variants in CHRNB2 and nausea severity was obtained after adjusting for age, gender and correlated tests in patients using varenicline for smoking cessation."}, {"pubmed": 21757735, "text": "an acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity"}, {"pubmed": 22359659, "text": "examined the effect of temperature on the electrophysiological properties of three neuronal nicotinic acetylcholine receptor subtypes: homomeric alpha7 nAChR, heteromeric alpha4beta2 nAChR and on alpha7 nAChRs containing a transmembrane mutation (L247T)"}, {"pubmed": 22553201, "text": "Data indicate that cytisine, varenicline, and nicotine are all high affinity binders for the alpha4beta2 nAChRs, but all display lower affinity for the alpha7 subtype receptor."}, {"pubmed": 23000369, "text": "NMR resolved multiple anesthetic binding sites in the TM domains of the alpha4beta2 nAChR"}, {"pubmed": 23037950, "text": "findings suggest that CHRNB2 rs4845652 T-allele carriers may be associated with lower levels of nicotine dependence (ND), and that certain allelic combinations of CHRNA4 and CHRNB2 might be correlated with higher ND levels."}, {"pubmed": 23429692, "text": "Following smoking reduction and cessation alpha4beta2* nAChR densities were decreased across brain regions."}, {"pubmed": 23437071, "text": "alpha4beta2-nAChR is a sensitive target to mediate oligomeric alpha-synuclein-induced modulation of cholinergic signaling."}, {"pubmed": 23734673, "text": "Data indicate that compounds showed favorable subtype selectivity for beta2*-nAChRs over beta4*-nAChRs."}, {"pubmed": 24850280, "text": "Smokers with less upregulation of available alpha4beta2* nAChRs have a greater likelihood of quitting with treatment than smokers with more upregulation."}, {"pubmed": 24982426, "text": "Data indicate the binding mode and modulatory mechanism of NS9283 at alpha4beta2 nicotinic acetylcholine receptors."}, {"pubmed": 25068303, "text": "Data show efficient expression of (alpha6beta2)2beta3 nicotinic acetylcholine receptors (AChRs) in Xenopus oocytes using free subunits with only small changes in alpha6 subunits, while not altering AChR pharmacology or channel structure."}, {"pubmed": 25640319, "text": "The results of this study suggested that rs2072660 had a significant effect on the nicotine dependence There was no direct association between depressive phenotype (with neither ZSDS total scores and nor its subscales) and CHRNB2 variants."}, {"pubmed": 25869137, "text": "analysis of how an agonist to the binding site promotes activation of alpha4beta2* nicotinic acetylcholine receptors"}, {"pubmed": 26644472, "text": "the identity of subunits neighboring the otherwise equivalent alpha4(+)/(-)beta2 agonist sites modifies their contributions to nAChR activation and E-loop residues are an important contributor to this neighbor effect"}, {"pubmed": 26858154, "text": "findings indicate that alterations in expression of the alpha4beta2 subtype of nAChR may be involved in the molecular mechanism(s) underlying the cognitive deficit associated with vascular dementia"}, {"pubmed": 26904947, "text": "MAFA controls autonomic nervous system-mediated insulin secretion by activating the transcription of nicotinic (ChrnB2 and ChrnB4) receptor genes, which is impaired in patients with type 2 diabetes."}, {"pubmed": 27445102, "text": "Reactive oxygen species, generated by 6-hydroxydopamine (6-OHDA), could cause the current rundown in alpha4beta2 nAChRs, which may play a role in Parkinson disease."}, {"pubmed": 27645992, "text": "This study shows that unorthodox acetylcholine binding sites can form at the alpha5/alpha4 and beta3/alpha4 interfaces in (alpha4beta2)2alpha5 and (alpha4beta2)2beta3 nicotinic acetylcholine receptors (nAChRs) and at the alpha4/alpha5 in (beta2alpha4)2alpha5 nAChRs."}, {"pubmed": 27698419, "text": "X-ray crystallographic structure of the human alpha4beta2 nicotinic receptor, the most abundant nicotinic subtype in the brain; structure provides insights into the architectural principles governing ligand recognition, heteromer assembly, ion permeation and desensitization in this prototypical receptor class"}, {"pubmed": 27721068, "text": "the mechanism of interaction between [Upsilon4E]GID and the agonist binding pockets of the alpha4beta2 and the halpha7 receptors, and to estimate their relative binding affinities, was investigated."}, {"pubmed": 27895161, "text": "The form containing three copies of alpha4 and two of beta2 was potentiated at low concentrations of acetylcholine chloride (ACh) and physostigmine, whereas the form containing two copies of alpha4 and three of beta2 was inhibited."}, {"pubmed": 28446611, "text": "Data suggest that amino acid residues alpha4Gly-41, alpha4Lys-64, and alpha4Thr-66 are critical for (alpha4)3(beta2)2 neuronal AChR potentiation by positive allosteric modulator (PAM) CMPI, but not by PAM NS9283; amino acid substitution at alpha4His-116, a known determinant of NS9283 binding and of agonist binding at alpha4:alpha4 subunit interface, did not reduce CMPI potentiation."}, {"pubmed": 28600847, "text": "The fifth subunit in the (alpha4beta2)2 beta2 receptor isoform modulates maximal ACh responses. This effect appears to be driven by a modulatory, and asymmetric, association with the alpha4(+)/beta2(-) agonist sites."}, {"pubmed": 29720657, "text": "cryoelectron microscopy and the structural principles of distinct assemblies of the human alpha4beta2 nicotinic receptor"}, {"pubmed": 31130483, "text": "Identification of the initial steps in signal transduction in the alpha4beta2 nicotinic receptor has been reported."}, {"pubmed": 32536355, "text": "Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy."}, {"pubmed": 32577853, "text": "The alpha7 and beta2 nicotinic acetylcholine receptor subunits regulate apoptosis in the infant hippocampus, and in sudden infant death syndrome (SIDS)."}, {"pubmed": 33657187, "text": "Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of alpha4beta2- nicotinic acetylcholine receptor intracellular structures."}], "genomic_pos": {"chr": "1", "end": 154580013, "ensemblgene": "ENSG00000160716", "start": 154567778, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 154552502, "start": 154540257, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0001666", "pubmed": 12189247, "qualifier": "involved_in", "term": "response to hypoxia"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006811", "pubmed": 8906617, "qualifier": "involved_in", "term": "monoatomic ion transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006816", "qualifier": "involved_in", "term": "calcium ion transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006939", "qualifier": "involved_in", "term": "smooth muscle contraction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007165", "pubmed": 8906617, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007268", "qualifier": "involved_in", "term": "chemical synaptic transmission"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007271", "qualifier": "involved_in", "term": "synaptic transmission, cholinergic"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007601", "qualifier": "involved_in", "term": "visual perception"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007605", "qualifier": "involved_in", "term": "sensory perception of sound"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007612", "pubmed": 15964197, "qualifier": "involved_in", "term": "learning"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007613", "pubmed": 15964197, "qualifier": "involved_in", "term": "memory"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007626", "qualifier": "involved_in", "term": "locomotory behavior"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0008306", "qualifier": "involved_in", "term": "associative learning"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008542", "pubmed": 15964197, "qualifier": "involved_in", "term": "visual learning"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0014059", "qualifier": "involved_in", "term": "regulation of dopamine secretion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0019233", "qualifier": "involved_in", "term": "sensory perception of pain"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021562", "qualifier": "involved_in", "term": "vestibulocochlear nerve development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021631", "qualifier": "involved_in", "term": "optic nerve morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021771", "qualifier": "involved_in", "term": "lateral geniculate nucleus development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021952", "qualifier": "involved_in", "term": "central nervous system projection neuron axonogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030890", "qualifier": "involved_in", "term": "positive regulation of B cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032225", "qualifier": "involved_in", "term": "regulation of synaptic transmission, dopaminergic"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0033603", "qualifier": "involved_in", "term": "positive regulation of dopamine secretion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0034220", "qualifier": "involved_in", "term": "monoatomic ion transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034220", "qualifier": "involved_in", "term": "monoatomic ion transmembrane transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035094", "pubmed": 12189247, "qualifier": "involved_in", "term": "response to nicotine"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035095", "pubmed": 17559419, "qualifier": "involved_in", "term": "behavioral response to nicotine"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035176", "qualifier": "involved_in", "term": "social behavior"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042053", "qualifier": "involved_in", "term": "regulation of dopamine metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042113", "qualifier": "involved_in", "term": "B cell activation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042220", "qualifier": "involved_in", "term": "response to cocaine"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042320", "qualifier": "involved_in", "term": "regulation of circadian sleep/wake cycle, REM sleep"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045471", "qualifier": "involved_in", "term": "response to ethanol"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045759", "qualifier": "involved_in", "term": "negative regulation of action potential"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048814", "qualifier": "involved_in", "term": "regulation of dendrite morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050877", "pubmed": 17900292, "qualifier": "involved_in", "term": "nervous system process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050890", "pubmed": 17559419, "qualifier": "involved_in", "term": "cognition"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0051899", "qualifier": "involved_in", "term": "membrane depolarization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051899", "qualifier": "involved_in", "term": "membrane depolarization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051963", "qualifier": "involved_in", "term": "regulation of synapse assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060079", "qualifier": "involved_in", "term": "excitatory postsynaptic potential"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060084", "qualifier": "involved_in", "term": "synaptic transmission involved in micturition"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0095500", "qualifier": "involved_in", "term": "acetylcholine receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0095500", "qualifier": "involved_in", "term": "acetylcholine receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1905144", "qualifier": "involved_in", "term": "response to acetylcholine"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005892", "qualifier": "part_of", "term": "acetylcholine-gated channel complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005892", "pubmed": 8906617, "qualifier": "part_of", "term": "acetylcholine-gated channel complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0009897", "qualifier": "located_in", "term": "external side of plasma membrane"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 8906617, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0042734", "qualifier": "located_in", "term": "presynaptic membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043005", "qualifier": "is_active_in", "term": "neuron projection"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0044853", "qualifier": "located_in", "term": "plasma membrane raft"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0045202", "qualifier": "is_active_in", "term": "synapse"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098981", "qualifier": "located_in", "term": "cholinergic synapse"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0099634", "qualifier": "located_in", "term": "postsynaptic specialization membrane"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [8663494, 27344019, 29720657], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0015276", "pubmed": 20438829, "qualifier": "enables", "term": "ligand-gated monoatomic ion channel activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015464", "qualifier": "enables", "term": "acetylcholine receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015464", "pubmed": 8906617, "qualifier": "enables", "term": "acetylcholine receptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0022848", "qualifier": "enables", "term": "acetylcholine-gated monoatomic cation-selective channel activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0022848", "pubmed": [8906617, 18387948], "qualifier": "enables", "term": "acetylcholine-gated monoatomic cation-selective channel activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0022848", "qualifier": "enables", "term": "acetylcholine-gated monoatomic cation-selective channel activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0022848", "pubmed": 20438829, "qualifier": "enables", "term": "acetylcholine-gated monoatomic cation-selective channel activity"}, {"category": "MF", "evidence": "IC", "id": "GO:0042166", "pubmed": 8906617, "qualifier": "enables", "term": "acetylcholine binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0042166", "pubmed": 15964197, "qualifier": "enables", "term": "acetylcholine binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0044877", "qualifier": "enables", "term": "protein-containing complex binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0050997", "qualifier": "enables", "term": "quaternary ammonium group binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:1901363", "qualifier": "enables", "term": "heterocyclic compound binding"}]}, "homologene": {"genes": [[7165, 1272986], [7227, 42918], [7955, 561906], [8364, 100101688], [9031, 395605], [9544, 716830], [9598, 740303], [9606, 1141], [9615, 490443], [9913, 517519], [10090, 11444], [10116, 54239]], "id": 595}, "interpro": [{"desc": "Nicotinic acetylcholine receptor", "id": "IPR002394", "short_desc": "Nicotinic_acetylcholine_rcpt"}, {"desc": "Neurotransmitter-gated ion-channel transmembrane domain", "id": "IPR006029", "short_desc": "Neurotrans-gated_channel_TM"}, {"desc": "Neurotransmitter-gated ion-channel", "id": "IPR006201", "short_desc": "Neur_channel"}, {"desc": "Neurotransmitter-gated ion-channel ligand-binding domain", "id": "IPR006202", "short_desc": "Neur_chan_lig-bd"}, {"desc": "Neurotransmitter-gated ion-channel, conserved site", "id": "IPR018000", "short_desc": "Neurotransmitter_ion_chnl_CS"}, {"desc": "Neurotransmitter-gated ion-channel transmembrane domain superfamily", "id": "IPR036719", "short_desc": "Neuro-gated_channel_TM_sf"}, {"desc": "Neurotransmitter-gated ion-channel ligand-binding domain superfamily", "id": "IPR036734", "short_desc": "Neur_chan_lig-bd_sf"}, {"desc": "Neuronal acetylcholine receptor", "id": "IPR038050", "short_desc": "Neuro_actylchol_rec"}], "ipi": "IPI00016869", "map_location": "1q21.3", "name": "cholinergic receptor nicotinic beta 2 subunit", "other_names": ["acetylcholine receptor, nicotinic, beta 2 (neuronal)", "beta2 human neuronal nicotinic acetylcholine receptor", "cholinergic receptor, nicotinic beta 2", "cholinergic receptor, nicotinic, beta 2 (neuronal)", "cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal)", "neuronal acetylcholine receptor subunit beta-2", "neuronal nicotinic acetylcholine receptor beta 2"], "pantherdb": {"HGNC": "1962", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "87891", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 10090, "uniprot_kb": "Q9ERK7"}, {"RGD": "2350", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 10116, "uniprot_kb": "P12390"}, {"Ensembl": "ENSGALG00000002707", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 9031, "uniprot_kb": "A0A3Q2U6P3"}, {"Gene": "CHRNB2", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 9031, "uniprot_kb": "P09484"}, {"ZFIN": "ZDB-GENE-120809-5", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7955, "uniprot_kb": "E7EYV5"}, {"ZFIN": "ZDB-GENE-090312-169", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7955, "uniprot_kb": "A0A2R8Q5R6"}, {"ZFIN": "ZDB-GENE-070821-3", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 7955, "uniprot_kb": "E7F4S7"}, {"WormBase": "WBGene00021941", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q8WTK7"}, {"WormBase": "WBGene00007191", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q17511"}, {"WormBase": "WBGene00000043", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q93149"}, {"WormBase": "WBGene00006765", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "P48181"}, {"WormBase": "WBGene00002974", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q27218"}, {"WormBase": "WBGene00000042", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "P48182"}, {"FlyBase": "FBgn0000038", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "P04755"}, {"WormBase": "WBGene00007903", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q93323"}, {"WormBase": "WBGene00022283", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "H2KZY7"}, {"FlyBase": "FBgn0000039", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "P17644"}, {"FlyBase": "FBgn0000036", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "P09478"}, {"WormBase": "WBGene00000047", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q23355"}, {"WormBase": "WBGene00000045", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q9N4M3"}, {"EnsemblGenome": "WBGene00000051", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "G5EDF1"}, {"WormBase": "WBGene00002975", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q93329"}, {"WormBase": "WBGene00006774", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q23022"}, {"WormBase": "WBGene00006797", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q9N587"}, {"FlyBase": "FBgn0266347", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "A0A0S0WNY8"}, {"FlyBase": "FBgn0004118", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "P25162"}, {"FlyBase": "FBgn0031261", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "Q9VPQ8"}, {"FlyBase": "FBgn0015519", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "Q9W3G6"}], "uniprot_kb": "P17787"}, "pathway": {"kegg": [{"id": "hsa04080", "name": "Neuroactive ligand-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04725", "name": "Cholinergic synapse - Homo sapiens (human)"}, {"id": "hsa05033", "name": "Nicotine addiction - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-181431", "name": "Acetylcholine binding and downstream events"}, {"id": "R-HSA-622323", "name": "Presynaptic nicotinic acetylcholine receptors"}, {"id": "R-HSA-622327", "name": "Postsynaptic nicotinic acetylcholine receptors"}, {"id": "R-HSA-629587", "name": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors"}, {"id": "R-HSA-629594", "name": "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"}, {"id": "R-HSA-629597", "name": "Highly calcium permeable nicotinic acetylcholine receptors"}], "smpdb": [{"id": "SMP00392", "name": "Benzocaine Action Pathway"}, {"id": "SMP00393", "name": "Bupivacaine Action Pathway"}, {"id": "SMP00394", "name": "Chloroprocaine Action Pathway"}, {"id": "SMP00395", "name": "Cocaine Action Pathway"}, {"id": "SMP00396", "name": "Dibucaine Action Pathway"}, {"id": "SMP00397", "name": "Levobupivacaine Action Pathway"}, {"id": "SMP00398", "name": "Lidocaine (Local Anaesthetic) Action Pathway"}, {"id": "SMP00399", "name": "Mepivacaine Action Pathway"}, {"id": "SMP00400", "name": "Oxybuprocaine Action Pathway"}, {"id": "SMP00401", "name": "Prilocaine Action Pathway"}, {"id": "SMP00402", "name": "Procaine Action Pathway"}, {"id": "SMP00403", "name": "Proparacaine Action Pathway"}, {"id": "SMP00404", "name": "Ropivacaine Action Pathway"}, {"id": "SMP00405", "name": "Codeine Action Pathway"}, {"id": "SMP00406", "name": "Morphine Action Pathway"}, {"id": "SMP00407", "name": "Heroin Action Pathway"}, {"id": "SMP00408", "name": "Methadone Action Pathway"}, {"id": "SMP00409", "name": "Oxycodone Action Pathway"}, {"id": "SMP00410", "name": "Hydromorphone Action Pathway"}, {"id": "SMP00411", "name": "Hydrocodone Action Pathway"}, {"id": "SMP00412", "name": "Oxymorphone Action Pathway"}, {"id": "SMP00413", "name": "Alfentanil Action Pathway"}, {"id": "SMP00414", "name": "Carfentanil Action Pathway"}, {"id": "SMP00415", "name": "Fentanyl Action Pathway"}, {"id": "SMP00416", "name": "Remifentanil Action Pathway"}, {"id": "SMP00417", "name": "Sufentanil Action Pathway"}, {"id": "SMP00422", "name": "Imipramine Action Pathway"}, {"id": "SMP00423", "name": "Desipramine Action Pathway"}, {"id": "SMP00424", "name": "Citalopram Action Pathway"}, {"id": "SMP00425", "name": "Escitalopram Action Pathway"}, {"id": "SMP00426", "name": "Fluoxetine Action Pathway"}, {"id": "SMP00431", "name": "Nicotine Action Pathway"}, {"id": "SMP00628", "name": "Nicotine Metabolism Pathway"}, {"id": "SMP00671", "name": "Tramadol Action Action Pathway"}, {"id": "SMP00672", "name": "Propoxyphene Action Pathway"}, {"id": "SMP00673", "name": "Levorphanol Action Pathway"}, {"id": "SMP00674", "name": "Anileridine Action Pathway"}, {"id": "SMP00675", "name": "Diphenoxylate Action Pathway"}, {"id": "SMP00676", "name": "Dezocine Action Pathway"}, {"id": "SMP00677", "name": "Levomethadyl Acetate Action Action Pathway"}, {"id": "SMP00678", "name": "Methadyl Acetate Action Pathway"}, {"id": "SMP00679", "name": "3-Methylthiofentanyl Action Pathway"}, {"id": "SMP00680", "name": "Dimethylthiambutene Action Pathway"}, {"id": "SMP00681", "name": "Ethylmorphine Action Pathway"}, {"id": "SMP00683", "name": "Levallorphan Action Pathway"}, {"id": "SMP00684", "name": "Buprenorphine Action Pathway"}, {"id": "SMP00685", "name": "Alvimopan Action Pathway"}, {"id": "SMP00686", "name": "Pentazocine Action Pathway"}, {"id": "SMP00687", "name": "Naltrexone Action Pathway"}, {"id": "SMP00688", "name": "Naloxone Action Pathway"}, {"id": "SMP00689", "name": "Dihydromorphine Action Pathway"}, {"id": "SMP00690", "name": "Ketobemidone  Action Pathway"}, {"id": "SMP00691", "name": "Nalbuphine Action Pathway"}], "wikipathways": [{"id": "WP1602", "name": "Nicotine Activity on Dopaminergic Neurons"}, {"id": "WP706", "name": "Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways"}]}, "pdb": ["2K58", "2K59", "2KSR", "2LM2", "5KXI", "6CNJ", "6CNK", "6UR8", "6USF", "8SSZ", "8ST0", "8ST1", "8ST2", "8ST3", "8ST4"], "pfam": ["PF02931", "PF02932"], "pharmgkb": "PA115", "pharos": {"target_id": 2798, "tdl": "Tclin"}, "pir": "S10505", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF218234", "relationship": "is"}, {"id": "GNF247467", "relationship": "is"}, {"id": "GNF247468", "relationship": "is"}, {"id": "GNF247469", "relationship": "is"}, {"id": "GNF247470", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081019", "relationship": "is"}, {"id": "GNF081020", "relationship": "is"}, {"id": "GNF081021", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051093", "relationship": "is"}, {"id": "GNF055860", "relationship": "is"}, {"id": "GNF060550", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065287", "relationship": "is"}, {"id": "GNF065288", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF278445", "relationship": "is"}, {"id": "GNF278600", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094360", "relationship": "is"}, {"id": "GNF134017", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_008027.1"], "protein": ["NP_000739.1", "XP_016855669.1", "XP_054190044.1"], "rna": ["NM_000748.3", "XM_017000180.3", "XM_054334069.1", "XR_001736952.3", "XR_008485885.1"], "translation": [{"protein": "XP_054190044.1", "rna": "XM_054334069.1"}, {"protein": "NP_000739.1", "rna": "NM_000748.3"}, {"protein": "XP_016855669.1", "rna": "XM_017000180.3"}]}, "reporter": {"HG-U133_Plus_2": ["206635_at", "241389_at"], "HG-U95Av2": "34154_at", "HTA-2_0": "TC01001279.hg.1", "HuEx-1_0": "2360346", "HuGene-1_1": "7905817", "HuGene-2_1": "16671494"}, "summary": "Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq, Jul 2008].", "symbol": "CHRNB2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413408"}, "unigene": "Hs.2306", "uniprot": {"Swiss-Prot": "P17787", "TrEMBL": ["A0A1B0GVD7", "Q5SXY3", "A0A1B0GTH5"]}, "wikipedia": {"url_stub": "CHRNB2"}}